Low-dose aspirin and upper gastrointestinal damage: epidemiology, prevention and treatment
about
Esomeprazole and aspirin fixed combination for the prevention of cardiovascular eventsGastrointestinal ulcers, role of aspirin, and clinical outcomes: pathobiology, diagnosis, and treatmentRisk factor profiles, drug usage, and prevalence of aspirin-associated gastroduodenal injuries among high-risk cardiovascular Japanese patients: the results from the MAGIC studyEffect of Low-dose, Enteric Coated Aspirin on Gastrointestinal Bleeding in Patients with Coronary Artery DiseaseImpact of blood type, functional polymorphism (T-1676C) of the COX-1 gene promoter and clinical factors on the development of peptic ulcer during cardiovascular prophylaxis with low-dose aspirinComparison of proton pump inhibitor and histamine-2 receptor antagonist in the prevention of recurrent peptic ulcers/erosions in long-term low-dose aspirin users: a retrospective cohort studyRisk management of risk management: Combining proton pump inhibitors with low-dose aspirinCost-utility of aspirin and proton pump inhibitors for primary preventionDiscontinuation of low dose aspirin and risk of myocardial infarction: case-control study in UK primary careRisk of Upper Gastrointestinal Bleeding in a Cohort of New Users of Low-Dose ASA for Secondary Prevention of Cardiovascular Outcomes.Long-term efficacy and safety of rabeprazole in patients taking low-dose aspirin with a history of peptic ulcers: a phase 2/3, randomized, parallel-group, multicenter, extension clinical trialStudy of the protective effect on intestinal mucosa of the hydrosoluble fiber Plantago ovata huskAntiplatelet therapy in acute coronary syndromes: current agents and impact on patient outcomes.OTC analgesics and drug interactions: clinical implications.Adherence to the preventive strategies for nonsteroidal anti-inflammatory drug- or low-dose aspirin-induced gastrointestinal injuries.The IL-1B Genetic Polymorphism Is Associated with Aspirin-Induced PepticUlcers in a Korean Ethnic Group.Clinical Risk Factors for Gastroduodenal Ulcer in Romanian Low-Dose Aspirin ConsumersGastrointestinal bleeding associated with low-dose aspirin use: relevance and management in clinical practice.Gastrointestinal effects of aspirin.Managing the adverse effects of nonsteroidal anti-inflammatory drugs.Acetylsalicylic acid/esomeprazole fixed-dose combination.Duration of anticoagulation treatment for thrombosis in APS: is it ever safe to stop?3rd Brazilian Consensus on Helicobacter pylori.Aspirin for cardioprotection and strategies to improve patient adherence.A benefit-risk assessment of the use of proton pump inhibitors in the elderly.Small bowel injury in low-dose aspirin users.Multinational, double-blind, randomised, placebo-controlled, prospective study of esomeprazole in the prevention of recurrent peptic ulcer in low-dose acetylsalicylic acid users: the LAVENDER study.Aspirin and omeprazole for secondary prevention of cardiovascular disease in patients at risk for aspirin-associated gastric ulcers.Frequency of nonsteroidal anti-inflammatory drug-associated ulcers.Markedly reduced toxicity of a hydrogen sulphide-releasing derivative of naproxen (ATB-346).Roles of NSAIDs and aspirin in bleeding peptic ulcers : NSAIDs, aspirin and peptic ulcers.High Serum Pepsinogen I and beta Helicobacter pylori Infection Are Risk Factors for Aspirin-Induced Gastroduodenal Injury.Time trends in incidence of peptic ulcer bleeding and associated risk factors in Norway 1985-2008.Prophylactic use of gastro-protective agents in patients on low-dose aspirin.Low-dose acetylsalicylic acid use and the risk of upper gastrointestinal bleeding: a meta-analysis of randomized clinical trials and observational studies.Clinical features of gastroduodenal injury associated with long-term low-dose aspirin therapy.The role of food for the formation and prevention of gastrointestinal lesions induced by aspirin in cats.Prevalence of Helicobacter pylori positivity in patients undergoing percutaneous coronary intervention.Risk factors of gastrointestinal bleeding in clopidogrel users: a nationwide population-based study.Helicobacter pylori infection and short-term intake of low-dose aspirin have different effects on alpha-1 antitrypsin/alpha-1 peptidase inhibitor (alpha1-PI) levels in antral mucosa and peripheral blood.
P2860
Q26995752-C2F2C0D0-7CBE-4A06-BC55-7913AF143BA6Q27027977-A63B0BB6-4D9E-4398-9809-D3DBB3D425A9Q33605890-18D460A7-FD78-4E6F-A276-E0F8E67FBAEFQ33855588-71002B06-E875-4DAD-B63C-174EA3D75D40Q34177563-A05BB778-4253-4688-AB19-E815746B5B69Q34251081-91AC9A0E-C5DE-4479-9F12-D56E284F0855Q35026472-2DD97DE3-B840-4965-9D3D-CBD881422F7CQ35108108-D6ADFA6B-149E-43A3-B324-DFF66C31376DQ35116433-A7F8944F-C65D-48BD-A7F0-CF1544B71525Q35117393-6524D139-956B-4EF8-A810-4C6503CE1D19Q35678985-FB0EB661-AA72-4BEF-AC22-0B45912384C9Q35759341-93CAA834-E167-4003-B90C-B661D408D9DCQ36160606-C11D0A4D-1C91-430F-9ADE-8F3CC55605D3Q36481601-74DAFBCD-5F4F-4577-A6C8-AC2F07968D6EQ36844540-852E55F2-5DAE-4D7C-8AB0-1CCC86ECF9C0Q36848931-CDC2E0E9-6D99-46D8-9A93-F128D255CE7DQ37192996-10948861-A1DD-4130-9FA7-014015367F4CQ37774375-92D7541A-C76E-4493-A142-ED4B1520AC5FQ37885723-5B50A722-0637-42F0-939B-B7C840A0E607Q37960540-1D76CD41-7A13-4AC2-83F2-D5C2BB4A5AA5Q37988928-83054773-C2ED-4911-A32E-195BCDB86747Q38089684-5528877C-0BBB-49B1-ADAD-978ABA25C508Q38113105-D5B5FC6E-D89C-4BA6-9005-E9F98D0274E3Q38176141-246D43B9-12BF-45F0-A3E0-5FD2FFC9DC49Q38196383-240F5CFA-9CF3-41F4-8CC8-B9C6380774C3Q38287025-9127CABD-315A-4B75-BEB4-DF59316E9809Q38439626-727916C1-9F9D-41D2-961E-E50C6D67DFBFQ38809179-BE4F1C96-B387-4AD6-8623-47B1C343FA02Q39611144-9B52E5D8-3522-4F32-B997-F2661CBE6145Q39884340-CFED31E7-C4F5-44D8-8DF0-326F6CACD3BEQ40086146-F2428888-9823-4A91-B353-96015313FB37Q40180037-E4B40301-13AF-4D46-855C-DE285EFC9D45Q42731841-C0E71922-9B02-4279-94A9-DBD32FFF3E4CQ43057611-5C944124-E801-4496-AD66-CC941EB18D0AQ43063064-A86E50F6-6C6A-4FB0-9B29-F6FF5F7546EAQ43216541-3CA0298C-0ED5-457D-BF68-4131E4C47C8FQ43561464-ED3D1DEC-D2E4-4703-BB1E-BC72B4536A01Q43732001-95AA5F76-800D-4090-842E-074932ECBED7Q43816156-BC159FEF-3A8C-46F3-8906-0B19F5347329Q43847142-4ADA748C-E043-42FA-A8DB-B6E94FC7C494
P2860
Low-dose aspirin and upper gastrointestinal damage: epidemiology, prevention and treatment
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Low-dose aspirin and upper gas ...... logy, prevention and treatment
@ast
Low-dose aspirin and upper gas ...... logy, prevention and treatment
@en
Low-dose aspirin and upper gas ...... logy, prevention and treatment
@nl
type
label
Low-dose aspirin and upper gas ...... logy, prevention and treatment
@ast
Low-dose aspirin and upper gas ...... logy, prevention and treatment
@en
Low-dose aspirin and upper gas ...... logy, prevention and treatment
@nl
prefLabel
Low-dose aspirin and upper gas ...... logy, prevention and treatment
@ast
Low-dose aspirin and upper gas ...... logy, prevention and treatment
@en
Low-dose aspirin and upper gas ...... logy, prevention and treatment
@nl
P3181
P356
P1476
Low-dose aspirin and upper gas ...... logy, prevention and treatment
@en
P2093
Angel Lanas
James Scheiman
P304
P3181
P356
10.1185/030079907X162656
P407
P577
2007-01-01T00:00:00Z